Agreed- commercialisation of substance is what the market craves....something that significantly affects the financials. The company is at a massive juncture. I reckon they need to concentrate on getting at least just one project to fruition ASAP to imbue holders with confidence about the other projects. The market will lap it up...Honeywell seemed to me be the no brainer for a quick win in this regard but not sure what is going on there. Cheers
SOR Price at posting:
26.0¢ Sentiment: None Disclosure: Not Held
